Clinical trials
Recruiting Phase 1/2 Thyroid Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut de Recherches Internationales Servier | 1 |
| ModeX Therapeutics, An OPKO Health Company | 1 |
| Sichuan Enray Pharmaceutical Sciences Company | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Lung Neoplasms | 3 |
| Colonic Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Head and Neck Neoplasms | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenocarcinoma | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.